[Form 4] BorgWarner Inc. Insider Trading Activity

Rhea-AI Filing Summary

Reporting person: Isabelle McKenzie (Vice President, officer).

Transaction: On 08/04/2025 Ms. McKenzie sold 5,000 shares of BorgWarner Inc. (BWA) common stock at $37.71 per share.

Holdings after transaction: 58,445 shares. The Form 4 was filed and signed by Miyuki P. Oshima as attorney-in-fact on 08/06/2025.

Insights

Securities Analyst

TL;DR: Insider sale of 5,000 BWA shares reported; disclosure is routine and the filing is complete.

The filing shows a non-derivative sale by Vice President Isabelle McKenzie of 5,000 common shares on 08/04/2025 at $37.71 per share, with post-transaction beneficial ownership of 58,445 shares. The Form 4 was executed by an attorney-in-fact and dated 08/06/2025. Based solely on the facts reported, this is a disclosed insider sale; the form contains no other transactions, derivative activity, or additional context to assess material impact.

Corporate Governance Expert

TL;DR: Timely Form 4 filing documents an officer sale; no governance issues or additional disclosures are present in the form.

The document identifies Isabelle McKenzie as an officer (Vice President) and reports a sale of 5,000 shares at $37.71. The filing was signed by Miyuki P. Oshima as attorney-in-fact on 08/06/2025. The Form 4 does not disclose any option exercises, grants, or plan-based transactions. Based on the submitted form alone, there are no further governance concerns evident in the disclosed information.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McKenzie Isabelle

(Last) (First) (Middle)

3850 HAMLIN ROAD

(Street)

AUBURN HILLS MI 48326

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BORGWARNER INC [ BWA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2025		S		5,000	D	$37.71	58,445	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Miyuki P. Oshima as attorney-in-fact for Isabelle McKenzie	08/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Isabelle McKenzie report on Form 4 for BWA?

The Form 4 reports a sale of 5,000 shares of BorgWarner Inc. common stock.

When was the transaction and at what price?

The sale occurred on 08/04/2025 at a price of $37.71 per share.

How many BWA shares does Isabelle McKenzie own after the transaction?

Following the reported sale, Ms. McKenzie beneficially owns 58,445 shares.

When was the Form 4 filed and who signed it?

The Form 4 was signed by Miyuki P. Oshima as attorney-in-fact and dated 08/06/2025.

What is Isabelle McKenzie's relationship to BorgWarner?

The filing identifies Isabelle McKenzie as a company Officer with the title Vice President.